Laval, QC, July 18, 2006 - Warnex Inc. (TSX: WNX) today announced that it has entered into an agreement in principle for the acquisition of the MDS Pharma Services pharmaceutics business located within its Blainville, Quebec facility. The Blainville pharmaceutics operations reported $6.7 million in annual revenue in its last fiscal year. “This significant acquisition reflects our strategy to grow both organically and through acquisitions,” said Mark Busgang, President and CEO of Warnex. “MDS’ pharmaceutics operation has an excellent reputation for quality and customer service, which will enhance Warnex’s leadership in the laboratory market in the province of Quebec.”
